Target intelligence / Profile preview

Eukaryotic translation initiation factor 2A (EIF2A)

Target
EIF2A
Molecular classification
Protein, Translation initiation factor
01

Overview

Eukaryotic translation initiation factor 2A (EIF2A) is a 65 kDa protein encoded by the EIF2A gene in humans and is distinct from the more widely studied heterotrimeric eIF2 complex, particularly the eIF2α subunit. While EIF2A has been implicated in alternative translation initiation mechanisms, possibly involving internal ribosome entry sites (IRESs) under stress conditions, its function and regulatory roles are not as well characterized as those of eIF2α or the eIF2 complex[3]. The major role of EIF2A appears to be facilitating the formation of puromycin-sensitive 80S preinitiation complexes, and it may have specific, debated roles in viral translation under stress[3]. Importantly, EIF2A should not be confused with the α subunit of the eIF2 complex (eIF2α), which undergoes phosphorylation in the integrated stress response (ISR) and is a major regulatory node in protein synthesis[1][2]. There is currently limited evidence that EIF2A is considered a therapeutic target, and it is not as biologically validated as eIF2α in canonical translation initiation or stress signaling. Further research is needed to fully clarify its physiological significance and disease associations.

Other names
CDA02MSTP004MSTP089eIF-2AEIF-2A65 kDa eukaryotic translation initiation factor 2AMST089eukaryotic translation initiation factor 2A, 65 kDaeukaryotic translation initiation factor 2A, 65kDa
02

Biological functions

Translation initiation

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 2A (EIF2A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 2A (EIF2A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call